Divis Laboratories gains on reporting 74% rise in Q2 net profit

11 Nov 2013 Evaluate

Divis Laboratories is currently trading at Rs. 1080.00, up by 59.65 points or 5.85% from its previous closing of Rs. 1020.35 on the BSE.

The scrip opened at Rs. 1051.20 and has touched a high and low of Rs. 1087.95 and Rs. 1051.20 respectively. So far 9,273 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1233.00 on 30-Nov-2012 and a 52 week low of Rs. 905.00 on 05-Aug-2013.

Last one week high and low of the scrip stood at Rs. 1089.80 and Rs. 977.15 respectively. The current market cap of the company is Rs. 14,335.00 crore.

The promoters holding in the company stood at 52.14% while Institutions and Non-Institutions held 28.37% and 19.49% respectively.

The company has reported 73.71% rise in its net profit at Rs 204.93 crore for the second quarter ended September 30, 2013 as compared to Rs 117.97 crore for the same quarter in the previous year. Total income of the company has increased by 25.15% at Rs 603.49 crore for quarter under review as compared to Rs  482.21 crore for the quarter ended September 30, 2012.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×